Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Cancer
|
January 13, 2025
Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada
Samuel Sassine, André P Ilinca, Hallie Coltin, et al.
Pediatrics
|
November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
The Lancet. Oncology
|
September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Leukemia
|
March 5, 2025
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Frédéric Millot, Mirella Ampatzidou, Nirmalya Roy Moulik, et al.
The Lancet. Haematology
|
February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study
Tanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Cancer
|
January 13, 2025
Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada
Samuel Sassine, André P Ilinca, Hallie Coltin, et al.
Pediatrics
|
November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.
The Lancet. Oncology
|
September 21, 2010
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E Lipshultz, Rebecca E Scully, Stuart R Lipsitz, et al.
Leukemia
|
March 5, 2025
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations
Frédéric Millot, Mirella Ampatzidou, Nirmalya Roy Moulik, et al.
The Lancet. Haematology
|
February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study
Tanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Page
of 5